Cohance Lifesciences Limited - Company Profile

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 2020.

2020 Mumbai, Maharashtra, India Amalgamated

Last Updated: November 10, 2025

About Cohance Lifesciences Limited

Cohance Lifesciences Limited, a amalgamated public limited company, was established on 06 July 2020 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100MH2020PLC402958. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3,499.94 Cr and a paid-up capital of ₹3,432.79 Cr.

Formerly known as Ai Pharmed Consultancy India Limited, Ai Pharmed Consultancy India Private Limited. It upholds a compliant status. Employing 27 professional, Its leadership includes Vinod Rao (Additional Director), Shweta Jalan (Director), Abhijit Mangalmoy Mukherjee (Director). Past directors included Shweta Jalan, Umesh Kanji Makwana, Abhijit Mangalmoy Mukherjee. It holds ₹563.47 Cr open charges and ₹299.77 Cr settled loans. Its latest AGM occurred on 12 July 2024, with the balance sheet filed on 31 March 2024. It is based at 215 Atrium, C Wing, 8Th Floor, 819-821, Andheri Kurla Road, Chakala, Andheri East, Mumbai, Maharashtra, 400093.

Company Details

CIN/LLPIN
U24100MH2020PLC402958
Registration Number
402958
Incorporation Date
06 July 2020
Authorized Capital
₹3,499.94 Cr
Paid-Up Capital
₹3,432.79 Cr
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Amalgamated

Key Metrics

Authorised Capital ₹ 3,499.94 Cr as on 10-11-2025
Paid Up Capital ₹ 3,432.79 Cr as on 10-11-2025
Company Age 5 Year, 7 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 563.47 Cr as on 10-11-2025
Satisfied Charges ₹ 299.77 Cr as on 10-11-2025

Comprehensive Company Insights

Explore comprehensive insights into Cohance Lifesciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Cohance Lifesciences Limited?

Current Directors

Name	Designation	Appointment Date	Status
Vinod Rao	Additional Director	17 Dec 2024	Current
Shweta Jalan	Director	12 Jul 2021	Current
Abhijit Mangalmoy Mukherjee	Director	27 Oct 2022	Current
Venkatanaga Kali Vetukuri Vara Prasada Raju	Managing Director	27 Oct 2022	Current
Pankaj Patwari	Director	20 Jul 2020	Current
Bhaskar Vemban Iyer	Director	27 Oct 2022	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	29 Dec 2021	Past
Pramod Abcsdd	Director	21 Jul 2020	Past
Pramod Abcsdd	Additional Director	05 Feb 2023	Past
Pramod Abcsdd	Director	31 Oct 2022	Past
Pramod Abcsdd	Director	31 Oct 2022	Past
Pramod Abcsdd	Company Secretary	-	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Cohance Lifesciences.

Cohance Lifesciences Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Cohance Lifesciences?

In 2024, Cohance Lifesciences had a promoter holding of 99.97% and a public holding of 0.03%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹5,634,727,276.00

Satisfied Charges

₹2,997,727,276.00

Charges Breakdown by Lending Institutions

Others : 126.10 Cr
Hdfc Bank Limited : 93.67 Cr
State Bank Of India : 80.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
10 Jul 2023	Hdfc Bank Limited	₹55.00 Cr	Satisfied
07 Jul 2023	Others	₹55.00 Cr	Satisfied
31 Oct 2022	Hdfc Bank Limited	₹38.67 Cr	Satisfied
15 Sep 2022	State Bank Of India	₹80.00 Cr	Satisfied
23 Sep 2019	Others	₹18.00 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Cohance Lifesciences?

Cohance Lifesciences has a workforce of 27 employees as of Sep 23, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Cohance Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cohance Lifesciences's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Cohance Lifesciences

Recent Activity within the Organization

Charges

Progress on A charge registered on 23 Sep 2019 via Charge ID 100294950 with Others was fully satisfied on 18 Dec 2024. was documented.
18 Dec 2024
Director Appointment

Vinod Rao was appointed as a Additional Director was appointed as a Additional Director on 17 Dec 2024 & has been associated with this company since 1 year 2 months . was recorded as a recent event.
17 Dec 2024
Director Appointment

Sudarsan Maddi was appointed as a CFO was appointed as a CFO on 22 Aug 2024 & has been associated with this company since 1 year 6 months . was recorded as a recent event.
22 Aug 2024
Annual General Meeting

Cohance Lifesciences Limited last Annual general meeting of members was held on 12 Jul 2024 as per latest MCA records. was recorded as a recent event.
12 Jul 2024
Charges

Progress on A charge registered on 07 Jul 2023 via Charge ID 100742978 with Others was fully satisfied on 29 Apr 2024. was documented.
29 Apr 2024
Balance Sheet

Progress on Cohance Lifesciences Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
31 Mar 2024

Explore recent activity and updates - View Recent Activity